Supply Chain Process Monitoring & Analyzing with ARIS PPM
|
|
- Marjory Armstrong
- 7 years ago
- Views:
Transcription
1 Supply Chain Process Monitoring & Analyzing with ARIS PPM Fast discovery approach on european wide supply chain process monitoring Jörg Kösterke European Supply Chain Management Business Processes & Projects Daiichi Sankyo Europe GmbH
2 Daiichi Sankyo around the World 8 June 2011 ProcessWorld
3 Figures for the Fiscal Year ,825 employees 100,125 shareholders 1.5 billion R&D expenditures 20.7 per cent R&D ratio 319 million net income 7.26 billion net sales Exchange rates (FY 2009): 131.2= 1 / 92.9=$1 8 June 2011 ProcessWorld
4 Consolidated Financial Highlights FY 2008/2009 Fiscal year * Net sales in bn. Operating income margin % 10.0% 10.2% Overseas sales to net sales 44.3% 50.7% 51.8% * Forecast figures Exchange rates: (FY 2008) 143.5= 1 / (FY 2009) 131.2= 1 / (FY 2010) 113.3= 1 8 June 2011 ProcessWorld
5 Global Ranking of Daiichi Sankyo Company 2009 sales (in bn.) Company 2009 sales (in bn.) 1. Pfizer Abbott Sanofi-Aventis Bayer Novartis Boehringer Ingelheim GlaxoSmithKline Amgen Roche Takeda AstraZeneca Teva Merck Novo Nordisk Johnson & Johnson Astellas Eli Lilly Daiichi Sankyo Bristol-Myers Squibb Otsuka 5.5 Source: Pharma Executives Magazine, May The listing ranks sales of human prescription drugs. Exchange rates as of March 2010: 131.2= 1 / 92.9=$1 8 June 2011 ProcessWorld
6 Ranking of Daiichi Sankyo in Japan in 2009 Company Country sales in bn. 1. Takeda Astellas Daiichi Sankyo Chugai (Roche) Mitsubishi Tanabe Eisai Novartis Pfizer GlaxoSmithKline Otsuka 1.9 Source: IMS Japan Pharmaceutical Market. All figures on distributor basis. Exchange rate: 131.2= 1 8 June 2011 ProcessWorld
7 Our Staff Worldwide As of 31 March June 2011 ProcessWorld
8 Our Staff in Europe 2,432 employees in Europe 248 employees based in Munich headquarters 1,341 field force employees 434 employees based in affiliates offices 409 employees in development and production As of 31 March June 2011 ProcessWorld
9 Our Locations in Europe Headquarters Affiliates Production sites Dublin London Amsterdam Brussels Paris Altkirch Pfaffenhofen Munich Vienna Zurich Madrid Rome Istanbul Lisbon 8 June 2011 ProcessWorld
10 Main Products in Europe Trade name Active ingredient Indication area Efient prasugrel prevention of atherothrombotic events Sevikar HCT olmesartan medoxomil + amlodipine besilate + hydrochlorotiazide hypertension Sevikar olmesartan medoxomil + amlodipine besilate hypertension Olmetec olmesartan medoxomil hypertension Olmetec Plus olmesartan medoxomil + hydrochlorotiazide hypertension Evista raloxifene osteoporosis Mevalotin pravastatin sodium hypercholesterolaemia Podomexef cefpodoxime proxetil bacterial infections Lopresor metroprolol extended release hypertension Lomir /Icaz isradipine hypertension 8 June 2011 ProcessWorld
11 Fast discovery approach on european wide supply chain process monitoring 8 June 2011 ProcessWorld
12 SAP Roll Out in Europe Dublin Madrid London Brussels Paris Altkirch Amsterdam Zurich Rome Pfaffenhofen Munich Vienna 2007: Launch of SAP (all modules in Headquarter and Pfaffenhofen Plant, in affiliates only FI & CO) 2009: Roll Out SD and MM in affiliates 2010: Roll Out Vendor Managed Inventory Istanbul Lisbon 8 June 2011 ProcessWorld
13 LSP Integration during SD & MM Roll Out 3 different Logistic Service Provider in 10 countries 2 scenarios 2 wholesalers had been integrated via interface Automatic data exchange via interfaces between systems 8 June 2011 ProcessWorld
14 Vendor Managed Inventory Affiliate Headquarter / Pfaffenhofen Plant Logistic Forecast Purchase Order Customer Order Production Plan Invoice Goods receipt Transport Goods issue Picking & shipping Delivery 8 June 2011 ProcessWorld
15 Reporting Areas at Daiichi Sankyo Europe GmbH Reports and queries in SAP To be defined!!! Reports and static graphical visualization 8 June 2011 ProcessWorld
16 Drivers For Process Monitoring Objectives Supported By Integrated Processes Business Process Analysis Process Performance Management Results Better processes Increased stability & agility Increase efficiency 8 June 2011 ProcessWorld
17 Objectives Process Monitoring Tool Monitor and optimize the established processes Business content is available out of the box Aggregation data on dashboard Available data of different SAP modules Limited Time frame 8 June 2011 ProcessWorld
18 Approach timeline Apr - May 2011 Aug Sep 2010 Oct 2010 RfP & Vendor Selection Nov 2010 Installation of pilot system Feb 2011 Implementation business content SD / MM Data validation on standard content Set up additional KPIs Roll out to affiliates 8 June 2011 ProcessWorld
19 Approach Fast Discovery Process Discovery Extract process performance data from applications Measure & analyze KPI s Online Process And Performance Monitoring Manage modernization process & interfaces Installation Application Virtual environment on ESX Farm 8 June 2011 ProcessWorld
20 Processes Monitored Cycle time Purchase order creation to goods receipt per plant Cycle time Goods issue to goods receipt per plant Cycle time Sales order creation to goods issue per plant Cycle time Sales order creation to approval 8 June 2011 ProcessWorld
21 Processes Monitored Cycle time Delivery creation to finish picking Cycle time Finish picking to goods issue Cycle time Purchase order creation to invoice creation Development of number of Purchase requisitions/purchase orders 8 June 2011 ProcessWorld
22 Comparable Processes Online Process And Performance Monitoring Comparing process performance in different countries by using filter values 8 June 2011 ProcessWorld
23 Process improvement with process monitoring Cycle time Goods issue DSE to Goods receipt affiliated company Calculated time for transportation maintained in SAP Material Master (used for calculation in SAP) Best guess approach 8 June 2011 ProcessWorld
24 Process improvement with process monitoring Cycle time Goods issue DSE to Goods receipt affiliated company Validation by using historic data in ARIS PPM New values were updated in SAP 8 June 2011 ProcessWorld
25 Process improvement Win more time (flexibility) for production Reduce total cycle time Decrease time to market Increase turnover of inventory 8 June 2011 ProcessWorld
26 Increase Transparency Cycle time Sales order creation to Goods issue LSP Monitoring Watch development regularly Find peaks Get more into detail Determine distribution 8 June 2011 ProcessWorld
27 Getting into Details Cycle time Sales order creation to Goods issue LSP Monitoring How many processes are outlying Find single process See date and time of single item Discuss with party in charge of 8 June 2011 ProcessWorld
28 Results Cycle time Sales order creation to Goods issue LSP Monitoring Monitor LSPs on our own Basis for regular meetings with LSP Monitor how stable interfaces are Compare different scenarios 8 June 2011 ProcessWorld
29 Lean Processes? Processes implemented as designed? How many special cases do we have? Are these really exceptions? How many changes do we have? Why? 8 June 2011 ProcessWorld
30 Conclusion Find most likely path Reduce manual work Improve processes Increase efficiency 8 June 2011 ProcessWorld
31 European Roll Out Training dashboard and analysis at affiliated companies Dublin Lisbon Madrid London Brussels Paris Altkirch Amsterdam Zurich Rome Pfaffenhofen Munich Vienna Discuss further figures and processes with every company Implement a regular KPI & process meeting Istanbul 8 June 2011 ProcessWorld
32 Next Steps Consolidation of figures Dublin London Brussels Paris Altkirch Amsterdam Zurich Pfaffenhofen Munich Vienna Creation of an implementation plan Implement further KPIs Improve processes Madrid Rome Istanbul Lisbon 8 June 2011 ProcessWorld
33 Jörg Kösterke Daiichi Sankyo Europe GmbH European Supply Chain Management Business Process & Projects 8 June 2011 ProcessWorld
34 Thank you!
CHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
More informationAnnual Press Conference 2012. Business Year 2011
Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation
More information6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors
More informationGlobal Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
More informationCommercial Insight Osteoarthritis and Rheumatoid Arthritis
A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and
More informationStakeholder Perspectives: Mild Cognitive Impairment and Dementia
A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?
More informationDecision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)
A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors
More informationGlobal Pharmaceuticals Marketing Channel Reference EDITION
Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry
More informationINCENTIVE COMPENSATION CONFERENCE
Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed
More informationehealthinsight Series: Online Patient Recruitment Strategies
A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient
More informationGlobal Peptide Therapeutics Market 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/3022209/ Global Peptide Therapeutics Market 2014-2018 Description: About Peptide Therapeutics Peptides are amino acids sequences
More informationPharma s Sharp Right Turn on R&D Creating an IT Platform to Fuel Future Growth
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Pharma s Sharp Right Turn on R&D Creating an IT Platform to Fuel Future Growth Leading pharmaceutical companies are evaluating
More informationPharma working capital performance highly variable
April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the
More informationPharma working capital leaves room for improvement
October 2012 Pharma working capital leaves room for improvement 50.7 Billion in Excess Working Capital Ten years ago it was not unusual to be asked why working capital mattered to a pharmaceutical company.
More informationCODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS
CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS Adopted November 2013, in force since 1 st of January 2014. INTRODUCTION The Association
More informationDigital Leaders Deal With a Range of Organizational Challenges
May 22, 2014 OVERCOMING OBSTACLES TO DIGITAL TRANSFORMATION SUCCESS IN THE PHARMACEUTICAL INDUSTRY Digital Leaders Deal With a Range of Organizational Challenges by Tim van Tongeren with Dennis van Rooij
More informatione-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017
More informationOutcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct
Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:
More informationBiotech Opportunities for Start-Up Firms in Japan and Asia
Biotech Opportunities for Start-Up Firms in Japan and Asia - Corporate VC s Perspective - Yoshitaka Yoneyama, Ph.D. President & CEO Astellas Venture Management LLC. April 25, 2006 About Astellas Pharma
More informationPharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies
Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies The Pharma Industry s Reputation in the Eyes of the General Public A Reputation Study with Consumers in 15 Countries RepTrak is a
More informationMultiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth
Brochure More information from http://www.researchandmarkets.com/reports/2640803/ Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine
More informationRx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
More informationProzessautomatisierung mit SAP Netweaver BPM bei Boehringer Ingelheim 20. Mai 2014
Prozessautomatisierung mit SAP Netweaver BPM bei Boehringer Ingelheim 20. Mai 2014 Dr. Torsten Grünewald Global Business Services / Process Management Boehringer Ingelheim Pharma GmbH&Co KG Boehringer
More informationSmall-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials
More informationBrochure More information from http://www.researchandmarkets.com/reports/3292678/
Brochure More information from http://www.researchandmarkets.com/reports/3292678/ Asia Pacific (India, China, Australia, South Korea & Others) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long
More informationDecember 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage
More informationIn the largest and perhaps the most ambitious collaborative
FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated
More informationKEEPING CLINICAL TRIALS IN AUSTRALIA
OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought
More informationValue Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector
Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector Fred Nijland Annemarie van Hoogstraten Nanning de Jong 1 Summary The Dutch market for the pharmaceutical and
More informationCommercial Perspectives: Multiple Sclerosis
A Datamonitor Report Commercial Perspectives: Multiple Sclerosis How to Find Opportunities in an Unremitting Market Published: Jun-04 Product Code: Providing you with: In-depth profiles of current market-leading
More informationCoaching Executives: Building Emotional Intelligence
IMPACT STORY Coaching Executives: Building Emotional Intelligence How a Global Airline Developed Emotionally Intelligent Leaders via an Integrated Coaching Solution The Challenge The Columbia Leadership
More informationSerialization Technology - Seidenader: Integral Solution Provider
Serialization Technology - Seidenader: Integral Solution Provider Sindusfarma August, 28th 2013 Dr. Stefan Loelkes Agenda 1 2 Your challenge Company overview 3 4 Integral solution provider Products 2 Your
More informationOFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013
Introduction OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013 In 2007, Attorney General Wasden filed lawsuits against 33 pharmaceutical companies for
More informationElectronic Health Records for Clinical Research. EHR Compliant to Clinical Trial Requirements. Oct 2009 1. Disclaimer
Electronic Health Records for Clinical EHR Compliant to Clinical Trial Requirements Mathias Poensgen EHRCR project / Aris Global Oct 2009 1 Disclaimer The views and opinions expressed in the following
More informationStakeholder Insight: Insulin Use in Type 2 Diabetes
A Datamonitor Report Stakeholder Insight: Insulin Use in Type 2 Diabetes From Last Resort to Early Intervention Published: May-04 Product Code: DMHC1989 Providing you with: Analysis of Datamonitor s Diabetes
More informationEvaluatePharma World Preview 2015, Outlook to 2020
EvaluatePharma World Preview 2015, Outlook to 2020 8th Edition June 2015 Welcome to the EvaluatePharma World Preview 2015, Outlook to 2020 The eighth edition of EvaluatePharma s World Preview brings together
More informationWHY DUBLIN? WHY NOW?
WHY DUBLIN? WHY NOW? 2 Why Dublin? Why Now? Introduction 3 Welcome to Dublin The investment story for Ireland is compelling right now. Dublin Glasgow Belfast Edinburgh Newcastle Liverpool Manchester Birmingham
More informationHealthcare, Regulatory and Reimbursement Landscape - Australia
Brochure More information from http://www.researchandmarkets.com/reports/2207850/ Healthcare, Regulatory and Reimbursement Landscape - Australia Description: Healthcare, Regulatory and Reimbursement Landscape
More informationBlockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global
Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar drarunj@gmail.com
More informationEU Clinical Trials Register
EU Clinical Trials Register Sponsor Contact Information Abbott Laboratories Ltd Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE UK Telephone number +44 1628 644475 euclinicaltrials@abbott.com
More informationTotal Compensation Measurement. Global TCM Participants. Turkey
Total Compensation Measurement 2008 Global TCM Participants Turkey Turkey 2008 TCM Participants Summary Information The table below lists key summary information on the 67 TCM participants for 2008. Measure
More informationMetastatic Breast Cancer - Pipeline Review, Q1 2011
Brochure More information from http://www.researchandmarkets.com/reports/1524592/ Metastatic Breast Cancer - Pipeline Review, Q1 2011 Description: Metastatic Breast Cancer - Pipeline Review, Q1 2011 Summary
More informationClinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management
Brochure More information from http://www.researchandmarkets.com/reports/2226324/ Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management Description:
More informationManaging Multiple Master Data Domains The Cintas Journey Phil Eaton Cintas Corporation Sudhendu Pandey SAP America
[ Managing Multiple Master Data Domains The Cintas Journey Phil Eaton Cintas Corporation Sudhendu Pandey SAP America [ Cintas Overview Founded in 1929 by Richard Doc Farmer as a small business to reclaim
More informationOpportunities in the China Healthcare Sector. December 2008
Opportunities in the China Healthcare Sector December 28 Opportunities in the China Healthcare Sector Executive Summary China s healthcare sector is rapidly developing Total Health expenditure in China
More informationPharmaceutical industry
8 th March 2016 Pharmaceutical industry 2015 Global ranking strategy decisive The annual company reporting season is always an exciting period. It is an ideal time to update our industry statistics and
More informationThe Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals
The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical
More informationusing the fully human ADLib system
Company Research and Analysis Report FISCO Ltd. http://www.fisco.co.jp 伪 伪 Focusing on improving technology to obtain antibodies using the fully human ADLib system (4583) (subsequently, the company ) is
More informationPharmaceutical Marketing Disclosures
Pharmaceutical Marketing Disclosures July 1, 2007 June 30, 2008 Report of Vermont Attorney General William H. Sorrell April 2009 Prepared by staff of the Vermont Attorney General s Office: Wendy Morgan,
More informationTeradata Analytics for SAP Solutions CTO Roadshow, Moscow. Ruud Blommaert, SAP COE Teradata International 26 th MAY, 2015
Teradata Analytics for SAP Solutions CTO Roadshow, Moscow Ruud Blommaert, SAP COE Teradata International 26 th MAY, 2015 A Questionnaire first: SAP ERP Customer? SAP BW Customer? SAP BusinessObjects Customer?
More informationGlobal Multiple Sclerosis Drugs Market 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/2925806/ Global Multiple Sclerosis Drugs Market 2014-2018 Description: About Multiple Sclerosis and Disease Types Multiple sclerosis
More informationVAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY
VAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY SUMMARY Healthcare Summary Personal health care expenditures projected to grow 26% in the next 4 years Hospital care sector comprises
More informationMain Conference Agenda
Sponsored by: (Co-located with Bioequivalence: Intersection between Science & Regulatory Conference) Main Conference Agenda Day One Wednesday, November 5 th, 2014 7:30 Registration Opens & Continental
More informationPHARMACEUTICAL INDUSTRY PROFILE
PHARMACEUTICAL INDUSTRY PROFILE I. INDUSTRY BACKGROUND A. Industry Definition The U.S. pharmaceutical industry is defined by the Census Bureau as companies engaged in researching, developing, manufacturing,
More informationEvolving tactical video production- Creative Studios
WHITEPAPER JUNE 2014 www.beroe-inc.com Evolving tactical video production- Creative Studios Abstract / Business Case 1. Introduction:This whitepaper help pharma clients who allocate lower budgets to their
More informationH04-01 Corporate Brochure Latest information www.daiichisankyo.com
Corporate Brochure Corporate Philosophy Global advances in medical technology and pharmaceuticals have saved the lives of a great many people and contributed to healthier lifestyles. However, there are
More informationScott Byrne & Rachel Weeks G400: Pharma Report 10/22/09 Direct to Consumer Advertising: The Affect on the Pharmaceutical Industry
Scott Byrne & Rachel Weeks G400: Pharma Report 10/22/09 Direct to Consumer Advertising: The Affect on the Pharmaceutical Industry A Glance at the Pharmaceutical Industry The pharmaceutical industry is
More informationMedical Writing Takes Off in India
Visit http://store.centerwatch.com to learn more about State of the Clinical Trials Industry 2008 Special Article Reprint For the latest news and views on the clinical trials industry visit ClinicalTrialsToday.com
More informationGlobal Growth Opportunities
Global Growth Opportunities Disclaimer This document is of a purely informative nature and does not constitute an offer to sell, exchange or buy, or the solicitation of an offer to buy, securities issued
More informationBaker s Dozen: 13 Ways Process Intelligence Drives Supply Chain Value
Baker s Dozen: 13 Ways Process Intelligence Drives Supply Chain Value Anthony Aming Enterprise Business and Applications Architect / Baker Hughes Anthony Aming, Baker Hughes Dave Brooks, Software AG Dave
More informationProcurement Improvement Plan
Procurement Improvement Plan Nuclear Special Interest Supply Chain Quality Group 30 April 2009 David Magrath Head of Procurement & Major Subcontracts Presentation Content Supply Chain Goals Some Facts
More informationCorporate Presentation. CMIC Co., Ltd. Chairman and CEO Kazuo Nakamura
Corporate Presentation CMIC Co., Ltd. Chairman and CEO Kazuo Nakamura Current Topics Dec.10 2007 Eisai announced its acquisition of US-based MGI Pharma Feb 4,2008 Amgen and Takeda announced their exclusive
More informationDaryl Fullerton. Oil & Gas Industry Principal
Daryl Fullerton Oil & Gas Industry Principal How increased visibility into e-invoicing & other P2P KPI Metrics speeds up Invoice Payment while also improving Operator / Supplier Relations PIDX EU Conference
More informationRx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency
Rx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency www.rx-360.org www.rx-360.org Presenter: Rob Welsh, VWR International, LLC VP Category Management
More informationPharmaceutical Distribution in the US: Current and Future Perspectives
Pharmaceutical Distribution in the US: Current and Future Perspectives Publication date: July 2009 Number of pages: 83 Author: Dr Faiz Kermani Pricing: 1,495 (PDF) / 1,550 (print) "In the US, the pharmaceutical
More informationIntegrated Project Management Solutions for Capital and Maintenance projects in SAP PS enhanced by Noveco epm
Integrated Project Management Solutions for Capital and Maintenance projects in SAP PS enhanced by Noveco epm Program and Project Management Long Term Strategic & Operational Portfolio Management Short
More informationProject Cost Planning, Forecasting and Reporting Solutions in SAP enhanced by Noveco epm 3.0
Project Cost Planning, Forecasting and Reporting Solutions in SAP enhanced by Noveco epm 3.0 Business Challenges Why Noveco epm? Solution Overview Business Challenges Symptoms: Your Project System is a
More informationIndian E-Retail Congress 2013
The Retail Track The Omni Channel Retail Supply Chain Indian E-Retail Congress 2013 Subhendu Roy Principal Consumer Industries and Retail Practice 15 February, 2013 Disclaimer This document is exclusively
More informationGlobal Pricing Study 2011: "Weak pricing cuts profits by 25%" Short summary
Global Pricing Study 2011: "Weak pricing cuts profits by 25%" Short summary August 2011 Bonn Office Haydnstr. 36, 53115 Bonn, Germany Tel.: +49 228 9843-351, fax: +49 228 9843-380 e-mail: bonn@simon-kucher.com
More informationCOMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun
More informationCOMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun
More informationThe clients we collaborated with to develop the pricing insights told us that they particularly valued:
JAPAN SALES, VOLUME, PRICING 2015 March 2015 EvaluatePharma s Japan Sales, Volume, Pricing Intelligence The size of the Japanese pharmaceutical market and the favourable payer environment makes it a key
More informationEXPERIENCE MORE FOR LESS WWW.STAYCITY.COM
EXPERIENCE MORE FOR LESS WWW.STAYCITY.COM Background Recognising that standard hotel rooms did not meet the needs of growing numbers of travellers, Staycity was founded in Dublin in 2004 to provide the
More informationNew Mid-Term Business Plan Sunrise 2012
New Mid-Term Business Plan Sunrise 2012 CHUGAI PHARMACEUTICAL CO.,LTD. President and CEO Osamu Nagayama January 30/31, 2008 Forward Looking Statements This presentation may include forward looking statements
More informationM&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends
M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends Symposium Life Science am Kapitalmarkt Frankfurt, 3. Juni 28 Global biotech industry Strong growth in most areas but Visible product
More informationPharmaceutical sales in Canada have a 2.5 percent share of the global market, making th
Industry Canada (/eic/site/icgc.nsf/eng/home) Home Industries and Business Canadian Life Science Industries Biopharmaceuticals and pharmaceuticals Pharmaceutical industry profile Life Science Industries
More informationRapidly Increasing Criminal and Civil Monetary Penalties Against the Pharmaceutical Industry: 1991 to 2010
Rapidly Increasing Criminal and Civil Monetary Penalties Against the Pharmaceutical Industry: 1991 to 2010 December 16, 2010 Sammy Almashat, M.D., M.P.H, Charles Preston, M.D., M.P.H, Timothy Waterman,
More informationConsolidated Financial Results. Fiscal 2006: (Year Ended March 31, 2008)
Consolidated Financial Results for Fiscal 2007 (Year Ended March 31, 2008) FASF May 13, 2008 Listed company name: DAIICHI SANKYO COMPANY, LIMITED Stock code number: 4568 Listed exchanges: Tokyo, Osaka,
More informationSwiss & Global AM HEALTHCARE : UN SECTEUR EN PLEINE SANTE
Picture Swiss & Global AM HEALTHCARE : UN SECTEUR EN PLEINE SANTE The exclusive manager of Julius Baer Funds. A member of the GAM group. Swiss & Global AM HEALTHCARE : UN SECTEUR EN PLEINE SANTE Christophe
More informationHow the Global Supply Chain Organization is Managing the Transition at Eli Lilly & Company. Ronald Bohl
How the Global Supply Chain Organization is Managing the Transition at Eli Lilly & Company September 2009 Ronald Bohl bohl_ron@lilly.com global research based pharmaceutical company dedicated to creating
More informationStakeholder Insight: Rheumatoid arthritis - Rising competition by line and severity
Brochure More information from http://www.researchandmarkets.com/reports/1383065/ Stakeholder Insight: Rheumatoid arthritis - Rising competition by line and severity Description: Introduction Disease-modifying
More informationLiquidity: Squeezing the Most out of Your Working Capital. Milan, February 8th
Liquidity: Squeezing the Most out of Your Working Capital Milan, February 8th Days Cash released from working capital generates value Improved cash flow is important in any economic environment Net working
More informationKey Findings. Use this report to... The Autoimmune Market Outlook to 2013
Key Findings The global autoimmune market generated sales of $31.9bn in, an increase of 14.4% over 2006 sales. The market is forecast to grow at a CAGR of 8.1% to reach a total value of $51.0bn in 2013.
More informationPhoto Credit: TURISMO MADRID. A Special Report on the REGION OF MADRID
Photo Credit: TURISMO MADRID A Special Report on the REGION OF MADRID Key Facts Madrid is one of the world s preferred locations for foreign investment due to its position as a leading global financial
More informationConsolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2009
FASF January 30, 2009 Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2009 Listed company name: DAIICHI SANKYO COMPANY, LIMITED Listed exchanges: Tokyo, Osaka,
More informationHow To Schedule A Lab
Online Exclusive from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE September/October 2012, Vol. 32 No. 5 www.pharmaceuticalengineering.org Copyright ISPE 2012 This article presents the various
More informationSPECIAL REPORT: OUTSOURCING HEAD IN THE CLOUDS OVER E-TMF DATA MINING FOR SERIALISATION: NO TIME TO DELAY
Volume 85 Number 10 October 2014 Development Formulation Processing Outsourcing Packaging Equipment Ingredients Regulatory The new platform excipient for tablets, sachets and more first rate filler-binder
More informationEuropean Commission Approves EFIENT (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Takashi Shoda, President and Representative Director (Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)
More informationResource Scheduling in QC Laboratories
Reprinted from PHARMACEUTICAL ENGINEERING The Official Technical Magazine of ISPE November/December 2012, Vol 32, No 6 Copyright ISPE 2012 www.pharmaceuticalengineering.org quality systems in QC Laboratories
More informationNAVSEA Enterprise Resource Planning Overview March 2011
NAVSEA Enterprise Resource Planning Overview March 2011 Mark Montella NUWC Newport ERP Site Implementation Lead 7 Months Until NAVSEA WCF Go-Live Navy Navy ERP ERP What is it? Navy Enterprise Resource
More informationDelivering a Comprehensive Serialization Traceability Program Peggy Staver - Pfizer
Delivering a Comprehensive Serialization Traceability Program Peggy Staver - Pfizer Overview Pfizer History What it Takes Strategies Organization Solutions Business-as-Usual Summary April 21, 2015 2 Pfizer
More informationChapter 5. Using bibliometrics to inform cancer research policy and spending
Chapter 5 Using bibliometrics to inform cancer research policy and spending Richard Sullivan, Seth Eckhouse and Grant Lewison for the European Cancer Research Managers Forum Richard Sullivan is chairman
More informationINTERNATIONAL PHARMACEUTICAL PRIVACY CONSORTIUM COMMENTS IN RESPONSE TO THE CALL FOR EVIDENCE ON EU DATA PROTECTION PROPOSALS
INTERNATIONAL PHARMACEUTICAL PRIVACY CONSORTIUM COMMENTS IN RESPONSE TO THE CALL FOR EVIDENCE ON EU DATA PROTECTION PROPOSALS I. INTRODUCTION The International Pharmaceutical Privacy Consortium (IPPC)
More informationMid-Term Business Plan 100B AGAIN!
2012-2014 100B AGAIN! 1 (6737) Table of Contents I II III Direction Global Network Sales Targets IV Business Plan (by Product & Business Unit) V R&D VI Basic Policy on Profit Distribution Disclaimer Regarding
More informationDESIGNED FOR YOUR INDUSTRY. SCALED TO YOUR BUSINESS. READY FOR YOUR FUTURE. SAP INDUSTRY BRIEFING FOR ELEVATOR, ESCALATOR AND MOVING SIDEWALK
Photo courtesy of Schumacher Elevator Company DESIGNED FOR YOUR INDUSTRY. SCALED TO YOUR BUSINESS. READY FOR YOUR FUTURE. SAP INDUSTRY BRIEFING FOR ELEVATOR, ESCALATOR AND MOVING SIDEWALK MANUFACTURERS
More informationKEY FACTS ON CORPORATE FOUNDATIONS
April 2011 KEY FACTS ON CORPORATE FOUNDATIONS Outlook for Corporate Foundation Giving Giving by the nation s approximately 2,700 grantmaking corporate foundations remained basically unchanged in 2010 at
More informationMessage from the Partners
In Brief In Brief March 2016 Our primary responsibility is for the interests of our clients. As a matter of principle all partners are available to meet clients and do so regularly. 1 Message from the
More informationBreast Cancer Drug Discoveries: What the Future Holds
Brochure More information from http://www.researchandmarkets.com/reports/679630/ Breast Cancer Drug Discoveries: What the Future Holds Description: In 2010, almost 50% of breast cancer sales were due to
More informationAccenture Life Sciences. Helping Life Sciences companies rethink, reshape or restructure for better patient outcomes
Accenture Life Sciences Helping Life Sciences companies rethink, reshape or restructure for better patient outcomes The Life Sciences industry is at a remarkable inflection point. As the Life Sciences
More informationL.I. Group. The Healthcare Technology Venture Market in Europe, UK and Yorkshire & Humber
L.I. Group The Healthcare Technology Venture Market in Europe, UK and Yorkshire & Humber About Library Innovation Group (L.I. Group) The L.I. Group was formed as a spin-out company from the Library House
More information